SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ: SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Skye and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...
2024-07-28 11:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Wolfspeed, Inc. - WOLF
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Wolfspeed, Inc. ("Wolfspeed" or the "Company") (NYSE: WOLF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Wolfspeed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...
2024-07-28 11:15 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ServiceNow, Inc. - NOW
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of ServiceNow, Inc. ("ServiceNow" or the "Company") (NYSE: NOW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ServiceNow and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...
2024-07-28 11:15 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines - ICU
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against SeaStar Medical Holding Corporation ("SeaStar" or the "Company") (NASDAQ: ICU) and certain officers. The class action, filed in the United States District Court for the District of Colorado, and docketed under 24-cv-01873, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired SeaStar securities...
2024-07-28 10:18 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Roblox Corporation - RBLX
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against Roblox Corporation ("Roblox" or the "Company") (NYSE: RBLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether...
2024-07-28 10:18 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Lamb Weston Holdings, Inc. - LW
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against Lamb Weston Holdings, Inc. ("Lamb Weston" or the "Company") (NYSE: LW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns...
2024-07-28 10:17 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against 2U, Inc. - TWOU
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against 2U, Inc. ("2U" or the "Company") (NASDAQ: TWOU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether 2U and certain of...
2024-07-28 10:17 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. - HUM
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Humana and...
2024-07-28 10:17 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LegalZoom.com, Inc. - LZ
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of LegalZoom.com, Inc. ("LegalZoom" or the "Company") (NASDAQ: LZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LegalZoom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...
2024-07-28 10:17 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lasertec Corporation - LSRCF
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Lasertec Corporation ("Lasertec" or the "Company") (OTC Pink: LSRCF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lasertec and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining...
2024-07-28 10:17 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sprinklr, Inc. - CXM
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Sprinklr, Inc. ("Sprinklr" or the "Company") (NYSE: CXM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sprinklr and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STMicroelectronics N.V. - STM
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of STMicroelectronics N.V. ("ST" or the "Company") (NYSE: STM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ST and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United States Steel Corporation - X
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of United States Steel Corporation ("U.S. Steel" or the "Company") (NSYE: X). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether U.S. Steel and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CrowdStrike Holdings, Inc. - CRWD
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of CrowdStrike Holdings, Inc. ("CrowdStrike" or the "Company") (NASDAQ: CRWD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CrowdStrike and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVX
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of HilleVax, Inc. ("HilleVax" or the "Company") (NASDAQ: HLVX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether HilleVax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc. ("OMI" or the "Company") (NYSE: OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether OMI and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Moderna and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RH - RH
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of RH ("RH" or the "Company") (NYSE: RH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RH and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 13, 2024,...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Ovid Therapeutics Inc. ("Ovid" or the "Company") (NASDAQ: OVID). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ovid and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class...
2024-07-28 10:16 AM EDT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL
New York, New York--(Newsfile Corp. - July 28, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmaceuticals, Inc. ("Zentalis" or the "Company") (NASDAQ: ZNTL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zentalis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about...
2024-07-28 10:16 AM EDT